Thomas Reuters says it plans to sell its $450 million healthcare business that provides provides data, analytics and performance benchmarking solutions and services to companies, government agencies and healthcare professionals. The company says the step is being taken to concentrate on core markets.

Among the products and services going up for sale are MarketScan, Advantage Suite, Micromedex, CareDiscovery and ActionOI. In a statement, Thomson CEO Tom Glocer said although the business is growing and profitable, the unit lacks integration with the other units and also lacks global scale. As a result of the divestitute, the Intellectual Property and Science businesses will be part of a a single operating unit of the Professional division.